Overview
- Description
The company develops innovative small molecule therapies targeting the tumor-stroma-immune interface to treat hard-to-treat cancers with minimal toxicity.
- Website
- Country
- The Netherlands
- Sector
- Health Biotechnology
iOnctura BV
Developing a portfolio of drug candidates to address several types of severe cancers